FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030352785> ?p ?o ?g. }

• W2030352785 endingPage "19" @default.
• W2030352785 startingPage "19" @default.
• W2030352785 abstract "Michael Vlessides is a freelance writer in Canmore, Alta. KANANASKIS, ALTA. — Physicians looking for a quick and easy way to predict fracture risk may need to look no further than a new computer program that considers more than just bone mineral density in making such determinations and summarizes its findings in a report on the patient. Developed by rheumatologist William Bensen, MD, the Bone DESTINY software program predicts fractures more reliably than do bone mineral density (BMD) assessments alone. Use of the Bone DESTINY program achieves prediction accuracy comparable to that attained by following the guidelines developed by Osteoporosis Canada (Can. Assoc. Radiol. J. 2005;56:178-88), said Dr. Bensen. Bone DESTINY is free to physicians and is currently being used in the Hamilton, Ont., area. It has not been released for general use yet, but there are plans to make it available throughout Canada, the United States, and Europe. It has been funded by Dr. Bensen and the division of rheumatology at McMaster University, Hamilton. The World Health Organization has also recently made available a simple, online tool for predicting a person's 10-year fracture risk. According to AMDA's clinical practice guideline “Osteoporosis and Fracture Prevention in the Long-Term Care Setting,” WHO's FRAX tool “is based on individual patient models that integrate the risks associated with clinical risk factors as well as BMD at the femoral neck.” The FRAX tool is available online at www.shef.ac.uk/FRAX/. One significant advantage of the FRAX tool in the long-term care setting is that it doesn't require a bone mineral density to assess risk status. “Bone DESTINY begins with bone density, then adds a number of other important risk factors,” said Maggie Larché, MD, PhD, a rheumatologist at McMaster University. “These include age, steroid use, propensity to fall, history of previous falls, body mass index, and previous fragility fractures. “These data are plugged into a handheld computer, which then generates a neat graphic with a color-coded representation of the patient's risk.” The program's five color codes represent fracture risk; patients at high (red) or very high (purple) risk for fracture are recommended for treatment. The program also produces an accompanying text report. In the first of two studies presented at the annual meeting of the Canadian Rheumatology Association, Dr. Larché and her colleagues at McMaster studied the predictive value of the Bone DESTINY program in 14,812 postmenopausal women at least 60 years old. For each patient, a set of treatment recommendations was produced based on BMD alone, on Osteoporosis Canada (OC) guidelines, or on Bone DESTINY results. Among 7,049 patients aged 60-69 years, BMD analysis alone recommended treatment in 19%. By comparison, 20% were recommended for treatment according to the OC guidelines, and 28% according to Bone DESTINY. In 5,252 patients aged 70-79 years, 29% were recommended for treatment based on BMD alone, 43% according to Bone DESTINY, and 51% according to the OC guidelines. In 2,511 patients at least 80 years old, 47%, 72%, and 77% would be recommended for treatment according to BMD, the OC guidelines, and Bone DESTINY results, respectively. A second study compared predictive values of the three methods in 572 men and 3,914 women (50 years and older) who had suffered at least one previous fragility fracture. For all age groups, both Bone DESTINY and OC guidelines recommended treatment in 80% of the women to prevent another fracture; 35% of the women would have received treatment based on BMD alone, Dr. Larché reported. The most significant difference, however, was observed in men, in whom Bone DESTINY recommended treatment in 73%, compared with 26% by BMD alone and 41% by the OC guidelines. In an interview, Dr. Larché said these differences may be explained by the weighting of such risk factors as history of falls and propensity to fall, which the OC guidelines do not consider. “We feel they are underestimating rather than we are overestimating the fracture risk, but that's still to be determined. “In the end, Bone DESTINY has a very similar outcome to OC guidelines, but has the advantage of being very user-friendly,” she added. “The primary care physicians absolutely adore it, as do we.” Dr. Larché reported receiving honoraria from Amgen, Abbott, BMS, Pfizer, Schering, and GSK." @default.
• W2030352785 created "2016-06-24" @default.
• W2030352785 creator A5020005473 @default.
• W2030352785 date "2009-07-01" @default.
• W2030352785 modified "2023-10-18" @default.
• W2030352785 title "New Tools Assess Fracture Risk Quickly" @default.
• W2030352785 doi "https://doi.org/10.1016/s1526-4114(09)60189-x" @default.
• W2030352785 hasPublicationYear "2009" @default.
• W2030352785 type Work @default.
• W2030352785 sameAs 2030352785 @default.
• W2030352785 citedByCount "0" @default.
• W2030352785 crossrefType "journal-article" @default.
• W2030352785 hasAuthorship W2030352785A5020005473 @default.
• W2030352785 hasBestOaLocation W20303527851 @default.
• W2030352785 hasConcept C126322002 @default.
• W2030352785 hasConcept C127413603 @default.
• W2030352785 hasConcept C142724271 @default.
• W2030352785 hasConcept C146978453 @default.
• W2030352785 hasConcept C1862650 @default.
• W2030352785 hasConcept C2775854910 @default.
• W2030352785 hasConcept C2776541429 @default.
• W2030352785 hasConcept C2776886416 @default.
• W2030352785 hasConcept C2777525943 @default.
• W2030352785 hasConcept C2779974597 @default.
• W2030352785 hasConcept C2780182762 @default.
• W2030352785 hasConcept C2994343686 @default.
• W2030352785 hasConcept C44761211 @default.
• W2030352785 hasConcept C512399662 @default.
• W2030352785 hasConcept C71924100 @default.
• W2030352785 hasConceptScore W2030352785C126322002 @default.
• W2030352785 hasConceptScore W2030352785C127413603 @default.
• W2030352785 hasConceptScore W2030352785C142724271 @default.
• W2030352785 hasConceptScore W2030352785C146978453 @default.
• W2030352785 hasConceptScore W2030352785C1862650 @default.
• W2030352785 hasConceptScore W2030352785C2775854910 @default.
• W2030352785 hasConceptScore W2030352785C2776541429 @default.
• W2030352785 hasConceptScore W2030352785C2776886416 @default.
• W2030352785 hasConceptScore W2030352785C2777525943 @default.
• W2030352785 hasConceptScore W2030352785C2779974597 @default.
• W2030352785 hasConceptScore W2030352785C2780182762 @default.
• W2030352785 hasConceptScore W2030352785C2994343686 @default.
• W2030352785 hasConceptScore W2030352785C44761211 @default.
• W2030352785 hasConceptScore W2030352785C512399662 @default.
• W2030352785 hasConceptScore W2030352785C71924100 @default.
• W2030352785 hasIssue "7" @default.
• W2030352785 hasLocation W20303527851 @default.
• W2030352785 hasOpenAccess W2030352785 @default.
• W2030352785 hasPrimaryLocation W20303527851 @default.
• W2030352785 hasRelatedWork W2016689947 @default.
• W2030352785 hasRelatedWork W2065655528 @default.
• W2030352785 hasRelatedWork W2342783171 @default.
• W2030352785 hasRelatedWork W2358294432 @default.
• W2030352785 hasRelatedWork W2373476565 @default.
• W2030352785 hasRelatedWork W2620935677 @default.
• W2030352785 hasRelatedWork W3040608001 @default.
• W2030352785 hasRelatedWork W3123614562 @default.
• W2030352785 hasRelatedWork W2182784462 @default.
• W2030352785 hasRelatedWork W2481527488 @default.
• W2030352785 hasVolume "10" @default.
• W2030352785 isParatext "false" @default.
• W2030352785 isRetracted "false" @default.
• W2030352785 magId "2030352785" @default.
• W2030352785 workType "article" @default.